Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study

References

• Miller IF, Becker AD, Grenfell BT, et al. Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020;26:1212–1217.
   PubMed Web of Science ®Google Scholar
• Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868–873.
   PubMed Web of Science ®Google Scholar
• Opel DJ, Diekema DS, Ross LF. Should we mandate a COVID-19 vaccine for children? JAMA Pediatr. 2021;175:125–126.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing. Geneva; 2021. https://apps.who.int/iris/bitstream/handle/10665/341786/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.2-eng.pdf?sequence=1&isAllowed=y.
   Google Scholar
• Food & Drug Administration. FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age. Washington DC; 2021. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.
   Google Scholar
• Shay DK, Shimabukuro TT, DeStefano F. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA Cardiol. 2021. DOI:10.1001/jamacardio.2021.2821.
   PubMed Web of Science ®Google Scholar
• Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021. 23–385.
   PubMedGoogle Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385:1078–1090.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144:471–484.
   PubMed Web of Science ®Google Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2021. DOI:10.1038/s41591-021-01630-0.
   Web of Science ®Google Scholar
• Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021. DOI:10.1056/NEJMoa2110737.
   PubMed Web of Science ®Google Scholar
• Hause AM, Gee J, Baggs J, et al. COVID-19 vaccine safety in adolescents aged 12-17 years - United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1053–1058.
   PubMed Web of Science ®Google Scholar
• Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021;375:e068665.
   PubMedGoogle Scholar
• Centre for Health Protection. Hong Kong vaccination dashboard; 2021. [cited 2021 Aug 27]. https://www.covidvaccine.gov.hk/en/dashboard/totalFirstDose.
   Google Scholar
• World Health Organization. WHO coronavirus (COVID-19) dashboard; 2021. [cited 2021 Oct 3]. https://covid19.who.int/.
   Google Scholar
• Wan EYF, Chui CSL, Lai FTT, et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2021. DOI:10.1016/S1473-3099(21)00451-5.
   Web of Science ®Google Scholar
• Li X, Tong X, Yeung WWY, et al. Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis. 2021. DOI:10.1136/annrheumdis-2021-221571.
   Google Scholar
• Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following comirnaty vaccination. Clin Infect Dis. 2021. DOI:10.1093/cid/ciab989.
   PubMed Web of Science ®Google Scholar
• Lai FTT, Li X, Peng K, et al. Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine. Ann Intern Med. 2022. DOI:10.7326/M21-3700.
   Web of Science ®Google Scholar
• Lai FTT, Huang L, Chui CSL, et al. Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong. Nat Commun. 2022;13:411.
   PubMed Web of Science ®Google Scholar
• Li X, Tong X, Wong ICK, et al. Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study. Gut. 2022. DOI:10.1136/gutjnl-2021-326860.
   Web of Science ®Google Scholar
• Sing C-W, Tang CTL, Chui CSL, et al. COVID-19 vaccines and risks of hematological abnormalities: nested case-control and self-controlled case series study. Am J Hematol. 2022. DOI:10.1002/ajh.26478.
   PubMed Web of Science ®Google Scholar
• Xiong X, Wong CKH, Au ICH, et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid. 2022. DOI:10.1089/thy.2021.0684.
   PubMed Web of Science ®Google Scholar
• Wan EYF, Chui CSL, Wang Y, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Heal - West Pacific. 2022;21:100393.
   PubMedGoogle Scholar
• Census and Statistics Department. Population estimates; 2021. [cited 2021 Nov 9]. https://www.censtatd.gov.hk/en/scode150.html.
   Google Scholar
• World Health Organization. Background paper on Covid-19 disease and vaccines: prepared by the Strategic Advisory Group of Experts (SAGE) on immunization working group on COVID-19 vaccines, 22 December 2020. World Health Organization; 2020.
   Google Scholar
• Hong Kong Government. COVID-19 Vaccination Programme; 2021. [cited 2021 Aug 6]. https://doi.org/10.1001/jamapediatrics.2022.0101.
   Google Scholar
• Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977–982.
   PubMed Web of Science ®Google Scholar
• Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 20. MMWR Morb Mortal Wkly Rep. 2021;70:1094–1099.
   PubMed Web of Science ®Google Scholar
• Perez Y, Levy ER, Joshi AY, et al. Myocarditis Following COVID-19 mRNA vaccine: a case series and incidence rate determination. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2021. DOI:10.1093/cid/ciab926.
   Google Scholar
• Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021;326:1210–1212.
   PubMed Web of Science ®Google Scholar
• Li C, Chen Y, Zhao Y, et al. Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis. 2021. DOI:10.1093/cid/ciab707.
   Web of Science ®Google Scholar
• Sarkanen TO, Alakuijala APE, Dauvilliers YA, et al. Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev. 2018;38:177–186.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931.
   PubMed Web of Science ®Google Scholar
• White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11-7.
   PubMed Web of Science ®Google Scholar
• Leung GM, Tin KYK, O’Donnell O. Redistribution or horizontal equity in Hong Kong’s mixed public–private health system: a policy conundrum. Health Econ. 2009;18:37–54.
   PubMed Web of Science ®Google Scholar
• Wong AYS, Root A, Douglas IJ, et al. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ. 2016;352. DOI:10.1136/bmj.h6926.
   Google Scholar